Belén Zarranz

846 total citations
18 papers, 722 citations indexed

About

Belén Zarranz is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Belén Zarranz has authored 18 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 3 papers in Molecular Biology and 3 papers in Toxicology. Recurrent topics in Belén Zarranz's work include Synthesis and Biological Evaluation (18 papers), Synthesis and Reactions of Organic Compounds (11 papers) and Synthesis and biological activity (7 papers). Belén Zarranz is often cited by papers focused on Synthesis and Biological Evaluation (18 papers), Synthesis and Reactions of Organic Compounds (11 papers) and Synthesis and biological activity (7 papers). Belén Zarranz collaborates with scholars based in Spain, France and Peru. Belén Zarranz's co-authors include Ignacio Aldana, Andrés Jaso, Antonio Monge, Miguel Á. Ortega, Séverine Maurel, Michel Sauvain, María Alfaro, Hugo Cerecetto, Eric Deharo and Gabriela Aguirre and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Belén Zarranz

18 papers receiving 688 citations

Peers

Countries citing papers authored by Belén Zarranz

Since Specialization

Citations

This map shows the geographic impact of Belén Zarranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belén Zarranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belén Zarranz more than expected).

Fields of papers citing papers by Belén Zarranz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belén Zarranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belén Zarranz. The network helps show where Belén Zarranz may publish in the future.

Co-authorship network of co-authors of Belén Zarranz

This figure shows the co-authorship network connecting the top 25 collaborators of Belén Zarranz. A scholar is included among the top collaborators of Belén Zarranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belén Zarranz. Belén Zarranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Synthesis and Antimalarial Activity of New 3-Arylquinoxaline-2-carbonitrile Derivatives 2011 ·Arzneimittelforschung ·Belén Zarranz, Andrés Jaso, Ignacio Aldana, Antonio Monge, Séverine Maurel, Eric Deharo, Valérie Jullian, Michel Sauvain	22
2	Synthesis and Antimalarial Activity of New 3‐Arylquinoxaline‐2‐carbonitrile Derivatives. 2006 ·ChemInform ·Belén Zarranz, Andrés Jaso, Ignacio Aldana, Antonio Monge, Séverine Maurel, Eric Deharo, Valérie Jullian, Michel Sauvain	16
3	Antiplasmodial activity of 3-trifluoromethyl-2-carbonylquinoxaline di-N-oxide derivatives 2006 ·Revista Brasileira de Ciências Farmacêuticas ·Belén Zarranz, Andrés Jaso, Lı́dia Moreira Lima, Ignacio Aldana, Antonio Monge, Séverine Maurel, Michel Sauvain	32
4	Comparative Use of Solvent‐Free KF‐Al₂O₃ and K₂CO₃ in Acetone in the Synthesis of Quinoxaline 1,4‐Dioxide Derivatives Designed as Antimalarial Drug Candidates. 2006 ·ChemInform ·Lı́dia Moreira Lima, Belén Zarranz, A. Marín, Beatriz Solano, Esther Vicente, (unknown), Ignacio Aldana, Antonio Monge	1
5	Comparative use of solvent-free KF-A1₂O₃and K₂CO₃in acetone in the synthesis of quinoxaline 1,4-dioxide derivatives designed as antimalarial drug candidates 2005 ·Journal of Heterocyclic Chemistry ·Lı́dia Moreira Lima, Belén Zarranz, A. Marín, Beatriz Solano, Esther Vicente, (unknown), Ignacio Aldana, Antonio Monge	12
6	Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives 2004 ·Bioorganic & Medicinal Chemistry ·Belén Zarranz, Andrés Jaso, Ignacio Aldana, Antonio Monge	87
7	Quinoxaline N,N′-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure–activity relationships 2004 ·Bioorganic & Medicinal Chemistry Letters ·Gabriela Aguirre, Hugo Cerecetto, Rossanna Di Maio, Mercedes González, María Alfaro, Andrés Jaso, Belén Zarranz, Miguel Á. Ortega, Ignacio Aldana, (unknown)	71
8	Synthesis of New 2‐Acetyl and 2‐Benzoyl Quinoxaline 1,4‐Di‐N‐oxide Derivatives as anti‐Mycobacterium tuberculosis Agents. 2004 ·ChemInform ·Andrés Jaso, Belén Zarranz, Ignacio Aldana, Antonio Monge	3
9	Synthesis of New Quinoxaline-2-carboxylate 1,4-Dioxide Derivatives as Anti-Mycobacterium tuberculosis Agents 2004 ·Journal of Medicinal Chemistry ·Andrés Jaso, Belén Zarranz, Ignacio Aldana, Antonio Monge	196
10	Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives 2004 ·Bioorganic & Medicinal Chemistry ·Belén Zarranz	1
11	Antimalarial Activity of Some 7‐Chloro‐2‐quinoxalinecarbonitrile‐1,4‐di‐N‐oxide Derivatives. 2003 ·ChemInform ·Ignacio Aldana, Miguel Á. Ortega, Andrés Jaso, Belén Zarranz, (unknown), A. Giménez, Antonio Monge, Eric Deharo	8
12	Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents 2003 ·European Journal of Medicinal Chemistry ·Andrés Jaso, Belén Zarranz, Ignacio Aldana, Antonio Monge	95
13	Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-Oxide derivatives 2003 ·Bioorganic & Medicinal Chemistry ·Belén Zarranz, Andrés Jaso, Ignacio Aldana, Antonio Monge	109
14	Anti-malarial activity of some 7-chloro-2-quinoxalinecarbonitrile-1,4-di-N-oxide derivatives. 2003 ·PubMed ·Ignacio Aldana, Miguel Á. Ortega, Andrés Jaso, Belén Zarranz, (unknown), A. Giménez, Antonio Monge, Eric Deharo	9
15	Pyrazolo[3,4-b]quinoxalines. A new class of cyclin-Dependent kinases inhibitors 2002 ·Bioorganic & Medicinal Chemistry ·Miguel Á. Ortega, (unknown), Belén Zarranz, Andrés Jaso, Ignacio Aldana, Sophie Leclerc, Laurent Meijer, Antonio Monge	36
16	ChemInform Abstract: Anti‐Mycobacterium tuberculosis Agents Derived from Quinoxaline‐2‐carbonitrile and Quinoxaline‐2‐carbonitrile 1,4‐Di‐N‐oxide. 2002 ·ChemInform ·Miguel Á. Ortega, Yolanda Sáinz, (unknown), Andrés Jaso, Belén Zarranz, Ignacio Aldana, Antonio Monge	1
17	ChemInform Abstract: Antimycobacterial Activity of New Quinoxaline‐2‐carbonitrile and Quinoxaline‐2‐carbonitrile 1,4‐Di‐N‐oxide Derivatives. 2001 ·ChemInform ·Miguel Á. Ortega, (unknown), Andrés Jaso, Belén Zarranz, Iñigo Tirapu, Ignacio Aldana, Antonio Monge	3
18	Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives. 2001 ·PubMed ·(unknown), (unknown), Andrés Jaso, Belén Zarranz, Iñigo Tirapu, Ignacio Aldana, Antonio Monge	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact